All Stories

  1. Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience

    Article • Advances in Hematology, November 2019, Hindawi Publishing Corporation

    Eirini Glezou, Professor Panagiotis Tsirigotis , Vasiliki Pappa

  2. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine

    Article • Leukemia & Lymphoma, April 2019, Taylor & Francis

    Vasiliki Pappa, Dr Maria K Angelopoulou, Dr Mark W Lowdell, Professor Panagiotis Tsirigotis

  3. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile

    Article • Journal of Critical Care, April 2016, Elsevier

    Professor Panagiotis Tsirigotis

  4. Low Dose Alemtuzumab without Methotrexate for Gvhd Prevention

    Article • Biology of Blood and Marrow Transplantation, March 2016, Elsevier

    Professor Panagiotis Tsirigotis

  5. Strategies for improving the efficacy of donor lymphocyte infusion following stem cell transplantation

    Article • Immunotherapy, January 2016, Future Medicine

    Professor Panagiotis Tsirigotis

  6. Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins

    Article • Antimicrobial Agents and Chemotherapy, October 2015, ASM Journals

    Professor Panagiotis Tsirigotis , Dr Georgia Valsami

  7. A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

    Article • Annals of Hematology, July 2015, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  8. Pulmonary alveolar proteinosis: time to shift?

    Article • Expert Review of Respiratory Medicine, April 2015, Taylor & Francis

    Professor Panagiotis Tsirigotis , Anastasia Papaporfyriou

  9. Primary Amyloidosis Manifesting as Cholestatic Jaundice after Laparoscopic Cholecystectomy

    Article • Case Reports in Surgery, January 2015, Hindawi Publishing Corporation

    Professor Panagiotis Tsirigotis

  10. The expanding horizon of immunotherapy in the treatment of malignant disorders: Allogeneic hematopoietic stem cell transplantation and beyond

    Article • Annals of Medicine, June 2014, Taylor & Francis

    Professor Panagiotis Tsirigotis

  11. Long-Term Inhaled Granulocyte Macrophage–Colony-Stimulating Factor in Autoimmune Pulmonary Alveolar Proteinosis: Effectiveness, Safety, and Lowest Effective Dose

    Article • Clinical Drug Investigation, June 2014, Springer Science + Business Media

    Professor Panagiotis Tsirigotis , Anastasia Papaporfyriou

  12. Irradiated mononuclear cells express significantin vitrocytotoxic activity: promise forin vivoclinical efficacy of irradiated mismatched donor lymphocytes infusion

    Article • Immunotherapy, April 2014, Future Medicine

    Professor Panagiotis Tsirigotis

  13. Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation

    Article • Theranostics, January 2014, Ivyspring International Publisher

    Professor Panagiotis Tsirigotis

  14. The impact of an antimicrobial cycling strategy for febrile neutropenia in a haematology unit

    Article • Journal of Chemotherapy, October 2013, Taylor & Francis

    Professor Panagiotis Tsirigotis

  15. Autologous transplant in multiple myeloma with an augmented conditioning protocol

    Article • Leukemia & Lymphoma, April 2013, Taylor & Francis

    Professor Panagiotis Tsirigotis

  16. Pulmonary Hypertension in a Patient with T-cell Large Granular Lymphocytic Leukemia

    Article • PVRI Review, January 2013, Medknow

    Professor Panagiotis Tsirigotis

  17. Lobomycosis: A case from Southeastern Europe and review of the literature

    Article • Journal of Dermatological Case Reports, September 2012, Specjalisci Dermatolodzy

    Professor Panagiotis Tsirigotis , Professor Maria Dalamaga

  18. Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders

    Article • memo - Magazine of European Medical Oncology, June 2012, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  19. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab

    Article • Hematological Oncology, May 2012, Wiley

    Professor Panagiotis Tsirigotis

  20. Extracorporeal photopheresis: The Hellenic experience

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  21. Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease

    Article • Immunotherapy, April 2012, Future Medicine

    Professor Panagiotis Tsirigotis

  22. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  23. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The hellenic experience

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  24. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  25. Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: A study by the Hellenic association of hematology

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  26. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: The influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology

    Article • Transfusion and Apheresis Science, April 2012, Elsevier

    Professor Panagiotis Tsirigotis

  27. Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, March 2012, Elsevier

    Professor Panagiotis Tsirigotis

  28. CD20 expression in angioimmunoblastic T cell lymphoma

    Article • Leukemia & Lymphoma, November 2011, Taylor & Francis

    Professor Panagiotis Tsirigotis

  29. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia

    Article • Blood Coagulation & Fibrinolysis, September 2011, Wolters Kluwer Health

    Professor Panagiotis Tsirigotis

  30. Acute Gastrointestinal Graft-versus-Host Disease in Pediatric Patients: Serum Albumin on Day 5 from Initiation of Therapy Correlates with Nonrelapse Mortality and Overall Survival

    Article • Biology of Blood and Marrow Transplantation, July 2011, Elsevier

    Professor Panagiotis Tsirigotis

  31. The role of natural killer cells in hematopoietic stem cell transplantation

    Article • Annals of Medicine, March 2011, Taylor & Francis

    Professor Panagiotis Tsirigotis

  32. Acute apenditis in patient with acute promyelocytic leukemia

    Article • Leukemia Research, January 2011, Elsevier

    Professor Panagiotis Tsirigotis

  33. Pure Red Cell Aplasia due to B19 Parvovirus Infection after Autologous Stem Cell Transplantation

    Article • Case Reports in Transplantation, January 2011, Hindawi Publishing Corporation

    Professor Panagiotis Tsirigotis

  34. Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression

    Article • Leukemia Research, September 2010, Elsevier

    Professor Panagiotis Tsirigotis

  35. Rosuvastatin-Induced Thrombocytopenia

    Article • Southern Medical Journal, July 2010, Southern Medical Association

    Professor Panagiotis Tsirigotis

  36. The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis

    Article • Thrombosis Research, February 2010, Elsevier

    Professor Panagiotis Tsirigotis

  37. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS)

    Article • Annals of Hematology, October 2009, Springer Science + Business Media

    Professor Panagiotis Tsirigotis , Ms Panagiota Economopoulou

  38. Expression analysis of proteins involved in the non homologous end joining DNA repair mechanism, in the bone marrow of adult de novo myelodysplastic syndromes

    Article • Annals of Hematology, September 2009, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  39. Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma

    Article • Annals of Hematology, August 2009, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  40. Post-hematopoietic stem cell transplantion immune-mediated cytopenias

    Article • Immunotherapy, January 2009, Future Medicine

    Professor Panagiotis Tsirigotis

  41. ABO Incompatibility is Associated with Increased Non-Relapse and GVHD Related Mortality in Patients with Malignancies Treated with a Reduced Intensity Regimen: A Single Center Experience of 221 Patients

    Article • Biology of Blood and Marrow Transplantation, April 2008, Elsevier

    Professor Panagiotis Tsirigotis

  42. The nature of small intestinal mucositis: a video-capsule endoscopy study

    Article • Supportive Care in Cancer, February 2008, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  43. Monoclonal antibodies in the treatment of lymphoid malignancies

    Article • The Journal of Steroid Biochemistry and Molecular Biology, February 2008, Elsevier

    Professor Panagiotis Tsirigotis

  44. Monitoring aspirin treatment in patients with thrombocytosis: Comparison of the platelet function analyzer (PFA)-100 with optical aggregometry

    Article • Thrombosis Research, January 2008, Elsevier

    Professor Panagiotis Tsirigotis

  45. Hypermethylation of thep15INK4B gene promoter in B-chronic lymphocytic leukemia

    Article • American Journal of Hematology, September 2007, Wiley

    Professor Panagiotis Tsirigotis

  46. Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome

    Article • Rheumatology International, June 2007, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  47. Hematopoietic stem cell therapy for malignant diseases

    Article • Annals of Medicine, January 2007, Taylor & Francis

    Professor Panagiotis Tsirigotis

  48. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding

    Article • European Journal Of Haematology, November 2006, Wiley

    Professor Panagiotis Tsirigotis

  49. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen

    Article • British Journal of Haematology, June 2006, Wiley

    Professor Panagiotis Tsirigotis

  50. Biological response modifiers as adjuncts to stem cell transplantation

    Article • Expert Opinion on Biological Therapy, April 2006, Informa Healthcare

    Professor Panagiotis Tsirigotis

  51. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia

    Article • European Journal Of Haematology, March 2006, Wiley

    Professor Panagiotis Tsirigotis

  52. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes

    Article • European Journal Of Haematology, September 2005, Wiley

    Professor Panagiotis Tsirigotis

  53. Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis

    Article • Cancer Genetics and Cytogenetics, August 2005, Elsevier

    Professor Panagiotis Tsirigotis

  54. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group

    Article • European Journal Of Haematology, August 2005, Wiley

    Professor Panagiotis Tsirigotis

  55. Primary adrenal lymphoma presenting as Addison?s disease: case report and review of the literature

    Article • Annals of Hematology, July 2004, Springer Science + Business Media

    Professor Panagiotis Tsirigotis

  56. 2-Deoxycoformycin in the treatment of T-large granular lymphocyte leukemia

    Article • Leukemia Research, September 2003, Elsevier

    Professor Panagiotis Tsirigotis

  57. Thalidomide in the treatment of myelodysplastic syndrome with fibrosis

    Article • Leukemia Research, October 2002, Elsevier

    Professor Panagiotis Tsirigotis

  58. T-Cell-Rich B-Cell Lymphoma

    Article • Oncology, January 2001, Karger Publishers

    Professor Panagiotis Tsirigotis

  59. Splenectomy in patients with malignant non-Hodgkin's lymphoma

    Article • European Journal Of Haematology, March 2000, Wiley

    Professor Panagiotis Tsirigotis